Zura Bio Limited
NASDAQ:ZURABiotechnology
+$0.07 today
- Market cap
- $92.96M
- Beta
- 0.03
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$0.67
Volume 3.02M
Average 0.75M
Balance Sheet
Inspect the capital base behind the business.
Assets
$113.95M
FY 2025 · Annual
-36.5% YoYLiabilities
$12.41M
FY 2025 · Annual
-36.4% YoYEquity
$101.54M
FY 2025 · Annual
-36.5% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $225.6M |
| Other Current | $1.4M |
| Total Current Assets | $227.0M |
| PP&E (Net) | $125.0K |
| Other Non-current | $1.5M |
| Total Non-current Assets | $1.6M |
| Total Assets | $228.6M |
Analysis
Selected assets total $228.6M for Latest. The largest visible component is Cash & Equivalents at $225.6M, about 98.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| EFFECT | EFFECT filing | Nov 3, 2026 | |
| S-3 | S-3 filing | Oct 27, 2026 | |
| 8-K | Current report | Oct 27, 2026 | |
| 10-Q | Quarterly report | Oct 27, 2026 |
How much cash does ZURA have?
Zura Bio Limited (ZURA) reported $109.41M in cash and equivalents in fiscal 2025.
How much debt does ZURA carry?
Zura Bio Limited (ZURA) reported $0.00 of total debt, with net debt of -$109.41M.
Continue the stock analysis
Jump to another research area for this company.